416 related articles for article (PubMed ID: 10680749)
21. Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.
Pericleous C; Ferreira I; Borghi O; Pregnolato F; McDonnell T; Garza-Garcia A; Driscoll P; Pierangeli S; Isenberg D; Ioannou Y; Giles I; Meroni PL; Rahman A
PLoS One; 2016; 11(6):e0156407. PubMed ID: 27253369
[TBL] [Abstract][Full Text] [Related]
22. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
[TBL] [Abstract][Full Text] [Related]
23. Binding of complement component C1q to anti-beta2 glycoprotein I antibodies from patients with antiphospholipid syndrome.
Odorczuk M; Keil LB; DeBari VA
Inflamm Res; 1999 Oct; 48(10):524-6. PubMed ID: 10563468
[TBL] [Abstract][Full Text] [Related]
24. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
Hanly JG; Smith SA
J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
[TBL] [Abstract][Full Text] [Related]
25. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
[TBL] [Abstract][Full Text] [Related]
26. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
27. APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.
Suh-Lailam BB; Cromar A; Davis KW; Tebo AE
Int J Clin Exp Pathol; 2012; 5(3):210-5. PubMed ID: 22558475
[TBL] [Abstract][Full Text] [Related]
28. [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome].
Reshetniak TM; Derksen RV; Alekberova ZS; Horbach D; De Groot F; Nasonov EL; Kalashnikova LA; Match ES; Nasonova VA
Klin Med (Mosk); 1998; 76(3):36-40. PubMed ID: 9575746
[TBL] [Abstract][Full Text] [Related]
29. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
[TBL] [Abstract][Full Text] [Related]
30. IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis.
Kelchtermans H; Pelkmans L; de Laat B; Devreese KM
J Thromb Haemost; 2016 Aug; 14(8):1530-48. PubMed ID: 27279342
[TBL] [Abstract][Full Text] [Related]
31. Performance Characteristics of Commercial Immunoassays for the Detection of IgG and IgM Antibodies to β2 Glycoprotein I and an Initial Assessment of Newly Developed Reference Materials for Assay Calibration.
Willis R; Pierangeli SS; Jaskowski TD; Malmberg E; Guerra M; Salmon JE; Petri M; Branch DW; Tebo AE
Am J Clin Pathol; 2016 Jun; 145(6):796-805. PubMed ID: 27267373
[TBL] [Abstract][Full Text] [Related]
32. Role of anti-domain 1-β2 glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome.
De Craemer AS; Musial J; Devreese KM
J Thromb Haemost; 2016 Sep; 14(9):1779-87. PubMed ID: 27314634
[TBL] [Abstract][Full Text] [Related]
33. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
34. Immunoglobulin G is the only anti-beta-2-glycoprotein I isotype that associates with unprovoked thrombotic events among hospital patients.
Brusch A; Bundell C; Hollingsworth P
Pathology; 2014 Apr; 46(3):234-9. PubMed ID: 24614715
[TBL] [Abstract][Full Text] [Related]
35. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
36. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
[TBL] [Abstract][Full Text] [Related]
37. Combined search for anti-beta2-glycoprotein I and anticardiolipin antibodies in antiphospholipid syndrome: contribution to diagnosis.
Sanmarco M; Roll P; Gayet S; Oksman F; Johanet C; Escande A; Cohen JH; Chevailler A; Goetz J; Humbel RL; Sibilia J
J Lab Clin Med; 2004 Sep; 144(3):141-7. PubMed ID: 15454883
[TBL] [Abstract][Full Text] [Related]
38. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
Cucnik S; Kveder T; Krizaj I; Rozman B; Bozic B
Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898
[TBL] [Abstract][Full Text] [Related]
39. IgA class anti-beta2-glycoprotein I in patients with systemic lupus erythematosus.
Tsutsumi A; Matsuura E; Ichikawa K; Fujisaku A; Mukai M; Koike T
J Rheumatol; 1998 Jan; 25(1):74-8. PubMed ID: 9458206
[TBL] [Abstract][Full Text] [Related]
40. Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I.
McDonnell T; Artim-Esen B; Wincup C; Ripoll VM; Isenberg D; Giles IP; Rahman A; Pericleous C
Front Immunol; 2018; 9():2244. PubMed ID: 30323817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]